3

OWNERSHIP DOCUMENT

Company: Vanda Pharmaceuticals Inc.
Filed: May 18, 2015
Period of Report: May 15, 2015
Accession Number: 0001193805-15-000776

View Document ↗ View on SEC.gov ↗